Mullerian inhibiting substance levels and ovarian response
View Patent ↗Methods and kits are provided for assessing the ovarian reserve and predicting the ovarian response to fertility treatments in a female subject. The serum levels of MIS are shown to be positively correlated with the production and retrieval of mature oocytes and serve as prognostic indicators for the female response to fertility treatment. The MIS levels can be monitored prior to and during fertility treatment and are useful to adjust the timing and dosage of treatments in order to produce optimal outcome in individual patients, to avoid ovarian hyperstimulation, or to indicate cancellation of an unsuccessful treatment. MIS can also be administered to women to stimulate follicle development and to prevent depletion of ovarian reserve.
1. A method of assessing the risk of ovarian hyperstimulation because of ovulation induction in a subject comprising:
(a) determining a serum Mullerian inhibiting substance (MIS) level in said subject;
(b) determining the maximum estradiol (E 2 ) level and the number of oocytes in said subject;
(c) comparing said serum MIS level, maximum estradiol (E 2 ) level and the number of oocytes to a standard which correlates MIS level to the response level of maximum estradiol (E 2 ) and number of oocytes obtained after ovulation induction in ovarian hyperstimulation; and
(d) determining the risk of ovarian hyperstimulation in said subject.
2. The method of claim 1 , wherein said risk of ovarian hyperstimulation is assessed during ovulation induction.
3. The method of claim 1 wherein said risk of ovarian hyperstimulation is assessed prior to ovulation induction.